Lv4
499 积分 2021-12-17 加入
R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial
2个月前
已完结
R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial
2个月前
已完结
Optimization of immune checkpoint inhibitor treatment planning for relapsed or refractory extranodal NK/T cell lymphoma
4个月前
已完结
Abstract P1-19-02: Overall survival for first-line palbociclib plus letrozole vs letrozole alone for HR+/HER2- metastatic breast cancer patients in US real-world clinical practice
5个月前
已关闭
Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With AdvancedCDK4-Amplified Well-Differentiated or Dedifferentiated Liposarcoma
5个月前
已完结
PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study
5个月前
已完结
Tolerability of palbociclib in younger and older patients with advanced breast cancer
5个月前
已关闭
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer
5个月前
已完结
Palbociclib-induced subacute cutaneous lupus erythematosus
5个月前
已完结
抗肿瘤血管生成靶向药物的不良反应、发生机制及处理
2年前
已采纳
创伤弧菌败血症致急性坏死性筋膜炎一例
2年前
已驳回
脂滴与胞内细胞器互作研究进展
2年前
已采纳
皖公网安备34019202002308
